Loading…
A real‐life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis
Bellofiore, Claudia, Benvenuti, Pietro, Mina, Roberto, Basset, Marco, Foli, Andrea, Nanci, Martina, Nuvolone, Mario, Guida, Gianluigi, Attanasio, Andrea, Mussinelli, Roberta, Mangiacavalli, Silvia, Cartia, Claudio Salvatore, Masoni, Valeria, Palumbo, Michele, Cani, Lorenzo, Oliva, Stefania, Consoli, Ugo, Conticello, Concetta, Di Raimondo, Francesco, Arcaini, Luca, Bringhen, Sara, Merlini, Giampaolo, Palladini, Giovanni, Milani, Paolo
Published in Hematological oncology (01.07.2024)
Published in Hematological oncology (01.07.2024)
Get full text
Journal Article
Loading…
Usefulness of Contrast-Enhanced Intraoperative Ultrasound in Identifying Disappearing Liver Metastases from Colorectal Carcinoma After Chemotherapy
Arita, Junichi, Ono, Yoshihiro, Takahashi, Michiro, Inoue, Yosuke, Takahashi, Yu, Saiura, Akio
Published in Annals of surgical oncology (01.06.2014)
Published in Annals of surgical oncology (01.06.2014)
Get full text
Journal Article
Loading…
Treatment and Outcomes in Patients With Primary Cutaneous B-Cell Lymphoma: The BC Cancer Agency Experience
Hamilton, Sarah N., Wai, Elaine S., Tan, King, Alexander, Cheryl, Gascoyne, Randy D., Connors, Joseph M.
Published in International journal of radiation oncology, biology, physics (15.11.2013)
Published in International journal of radiation oncology, biology, physics (15.11.2013)
Get full text
Journal Article
Loading…
ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy
Vitale, Maria Giuseppa, Barbato, Carmela, Crispo, Anna, Habetswallner, Francesco, De Martino, Bernardo Maria, Riccardi, Ferdinando, Maione, Angela, Eisenwagen, Sandra, Vitale, Giovanna, Cartenì, Giacomo
Published in Molecules (Basel, Switzerland) (13.05.2020)
Published in Molecules (Basel, Switzerland) (13.05.2020)
Get full text
Journal Article
Loading…
A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Awan, Farrukh T., Hillmen, Peter, Hellmann, Andrzej, Robak, Tadeusz, Hughes, Steven G., Trone, Denise, Shannon, Megan, Flinn, Ian W., Byrd, John C.
Published in British journal of haematology (01.11.2014)
Published in British journal of haematology (01.11.2014)
Get full text
Journal Article
Loading…
Loading…
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
Ferris, Robert L., Moskovitz, Jessica, Kunning, Sheryl, Ruffin, Ayana T., Reeder, Carly, Ohr, James, Gooding, William E., Kim, Seungwon, Karlovits, Brian J., Vignali, Dario A.A., Duvvuri, Umamaheswar, Johnson, Jonas T., Petro, Daniel, Heron, Dwight E., Clump, David A., Bruno, Tullia C., Bauman, Julie E.
Published in Clinical cancer research (01.04.2022)
Published in Clinical cancer research (01.04.2022)
Get full text
Journal Article
Loading…
Loading…
Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment?
Crestani, Adrien, Benoit, Louise, Touboul, Cyril, Pasquier, Jennifer
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Loading…
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer
Hinchcliff, Emily M., Knisely, Anne, Adjei, Naomi, Fellman, Bryan, Yuan, Ying, Patel, Ami, Xu, Cai, Westin, Shannon N., Sood, Anil K., Soliman, Pamela T., Shafer, Aaron, Fleming, Nicole D., Gershenson, David M., Vikram, Raghunandan, Bathala, Tharakeswara, Vining, David, Ganeshan, Dhakshina M., Lu, Karen H., Sun, Charlotte C., Meyer, Larissa A., Jazaeri, Amir A.
Published in Cancer (01.04.2024)
Published in Cancer (01.04.2024)
Get full text
Journal Article
Loading…
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
Kotwinski, Paul, Smith, Gillian, Cooper, Jackie, Sanders, Julie, Ma, Louise, Teis, Albert, Kotwinski, David, Mythen, Michael, Pennell, Dudley J., Jones, Alison, Montgomery, Hugh
Published in PloS one (02.12.2016)
Published in PloS one (02.12.2016)
Get full text
Journal Article
Loading…
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy
Ohsumi, Shozo, Kiyoto, Sachiko, Takahashi, Mina, Hara, Fumikata, Takashima, Seiki, Aogi, Kenjiro, Matsuda, Miwa, Yamamura, Naomi, Doi, Miyuki
Published in Supportive Care in Cancer (01.01.2021)
Published in Supportive Care in Cancer (01.01.2021)
Get full text
Journal Article
Loading…
Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma
Matsubara, Nobuaki, Yonese, Junji, Kojima, Takahiro, Azuma, Haruhito, Matsumoto, Hiroaki, Powles, Thomas, Rosenberg, Jonathan E., Petrylak, Daniel P., Matsangou, Maria, Wu, Chunzhang, Campbell, Mary, Yamashiro, Mayumi
Published in Cancer medicine (Malden, MA) (01.02.2023)
Published in Cancer medicine (Malden, MA) (01.02.2023)
Get full text
Journal Article
Loading…
Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial
Stork, Linda C., Matloub, Yousif, Broxson, Emmett, La, Mei, Yanofsky, Rochelle, Sather, Harland, Hutchinson, Ray, Heerema, Nyla A., Sorrell, April D., Masterson, Margaret, Bleyer, Archie, Gaynon, Paul S.
Published in Blood (08.04.2010)
Published in Blood (08.04.2010)
Get full text
Journal Article
Loading…
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
Fox, Elizabeth, Widemann, Brigitte C., Pastakia, Devang, Chen, Clara C., Yang, Sherry X., Cole, Diane, Balis, Frank M.
Published in Cancer chemotherapy and pharmacology (01.12.2015)
Published in Cancer chemotherapy and pharmacology (01.12.2015)
Get full text
Journal Article
Loading…
The Optimal Timing and Duration of Daily G‐CSF for the Primary Prevention of Febrile Neutropenia in Breast Cancer Patients Undergoing Adjuvant TAC Chemotherapy
Kim, Zisun, Hur, Sung Mo, Lee, Jong Eun, Han, Sun Wook, Jung, Hae Il, Kim, Sung Yong, Lee, Jihyoun, Lim, Cheol Wan
Published in Asia-Pacific journal of clinical oncology (01.08.2025)
Published in Asia-Pacific journal of clinical oncology (01.08.2025)
Get full text
Journal Article
Loading…
Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer
Kashiwagi, Shinichiro, Asano, Yuka, Goto, Wataru, Takada, Koji, Takahashi, Katsuyuki, Hatano, Takaharu, Takashima, Tsutomu, Tomita, Shuhei, Motomura, Hisashi, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi
Published in Anticancer research (01.10.2017)
Published in Anticancer research (01.10.2017)
Get full text
Journal Article
Loading…
Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations
Świerzko, Anna S., Michalski, Mateusz, Sokołowska, Anna, Nowicki, Mateusz, Szala-Poździej, Agnieszka, Eppa, Łukasz, Mitrus, Iwona, Szmigielska-Kapłon, Anna, Sobczyk-Kruszelnicka, Małgorzata, Michalak, Katarzyna, Gołos, Aleksandra, Wierzbowska, Agnieszka, Giebel, Sebastian, Jamroziak, Krzysztof, Kowalski, Marek L., Brzezińska, Olga, Thiel, Steffen, Matsushita, Misao, Jensenius, Jens C., Gajek, Gabriela, Cedzyński, Maciej
Published in Frontiers in immunology (28.01.2020)
Published in Frontiers in immunology (28.01.2020)
Get full text
Journal Article
Loading…
PD-1/PD-L1 Inhibitors Plus Antiangiogenic Drugs Versus Sorafenib as the First Line Treatment for Advanced Hepatocellular Carcinoma: A Phase 3 RCTs Based Meta-Analysis
Li, Jun, Liao, Chun, Liu, Zhaohui, Xiong, Hu, Cai, Jing, Liu, Tiande
Published in Technology in cancer research & treatment (01.01.2024)
Published in Technology in cancer research & treatment (01.01.2024)
Get full text
Journal Article
Loading…
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer
Hochster, H. S., Uboha, N., Messersmith, W., Gold, P. J., ONeil, B. H., Cohen, D., Denlinger, C., Cohen, S., Leichman, C. G., Leichman, L.
Published in Cancer chemotherapy and pharmacology (01.01.2015)
Published in Cancer chemotherapy and pharmacology (01.01.2015)
Get full text
Journal Article